home / stock / rnxt / rnxt news

RNXT News and Press, RenovoRx Inc. From 11/13/25

Stock Information
Company Name: RenovoRx Inc.
Stock Symbol: RNXT
Market: NASDAQ
Website: renovorx.com
Menu
RNXT RNXT Quote RNXT Short RNXT News RNXT Articles RNXT Message Board
Get RNXT Alerts

News, Short Squeeze, Breakout and More Instantly...
RNXT - RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update

September 30, 2025 Cash and Cash Equivalents at $10 million Revenue Expected to Grow in 2026 and Continue to Offset Cash Burn Management to Host Conference Call Today at 4:30 p.m. ET MOUNTAIN VIEW, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (...
RNXT - Expected US Company Earnings on Thursday, November 13th, 2025

GRI Bio Inc. (GRI) is expected to report $-1.11 for Q3 2025 Meridian Mining UK Societas (MRRDF) is expected to report $-0.01 for Q3 2025 CaliberCos Inc. (CWD) is expected to report $-0.32 for Q3 2025 BioCorRx Inc (BICX) is expected to report $-0.06 for Q3 2025 Beneficient (BENF) i...

RNXT - RenovoRx Strengthens Scientific Advisory Board (SAB) with Pancreatic Cancer Expert Timothy Donahue, MD

MOUNTAIN VIEW, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath ® , a novel, FD...

RNXT - RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th

MOUNTAIN VIEW, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a life-sciences company developing innovative targeted oncology therapies and commercializing RenovoCath ® , a patented,...
RNXT - RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call on November 13th at 4:30 p.m. ET

MOUNTAIN VIEW, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath ® , a novel, FDA-cle...

RNXT - Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation

2025-10-17 09:50:31 ET https://markets-headlines.com/wp-content/uploads/2025/10/Natural-Killer-Cell-Therapies-Lead-254B-Immunotherapy-Market-Transformation.mp4 Equity Insider News Commentary Issued on be...

RNXT - RenovoRx Expands Scientific Advisory Board with Internationally Renowned Interventional Oncologist, Thierry de Baère, MD, PhD

LOS ALTOS, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath ® , a novel, FDA-cl...
RNXT - RenovoRx's PanTheR Post-Marketing Registry Study Progresses with First Clinical Procedure and Addition of Two Participating Clinical Sites

First Registry-Eligible Patient Procedure Commenced at the University of Vermont Cancer Center Baptist Health Miami Cancer Institute and University of Pittsburgh Medical Center Join the University of Vermont Cancer Center as Participating Clinical Sites The PanTheR Study is Ga...

RNXT - RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16th

MOUNTAIN VIEW, Calif., Sept. 11, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath ® , a patented...

RNXT - US Companies Moving the Markets, Morning edition
Fri, Aug 15, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Perfect Moment Ltd. (PMNT) rose 106.3% to $0.599001 on volume of 191,885,956 shares Dragonfly Energy Holdings Corp (DFLI) rose 36.2% to $0.361 on volume of 124,421,993 shares Opendoor Technologies Inc (OPEN) rose 4.6% to $3.18 on volume...
Previous 10 Next 10